Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro cannot be purchased through Klarna or any buy-now-pay-later service from a legitimate UK pharmacy. As a prescription-only medicine, it can only be dispensed following a clinical assessment by a registered prescriber — and that legal requirement shapes how payment works. Here is what that means in practice, and what your real options are.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth correcting first. Searches for Mounjaro on Klarna usually come from people who are thinking about cost and cashflow, not from people trying to sidestep medical rules. That is completely understandable, private weight-loss treatment costs real money, and spreading that cost sounds sensible. The problem is that buy-now-pay-later services like Klarna sit between a customer and a retailer. Regulated pharmacy dispensing of a prescription-only medicine is not that kind of transaction.
Before a single pen of Mounjaro can legally be dispensed, a GPhC-registered Independent Prescriber must review your medical information, assess your eligibility, and issue a prescription. That step cannot be initiated by a payment platform or skipped because a particular checkout method is available. The medicine comes after the clinical decision, always. Any seller offering to supply Mounjaro through Klarna, or via a checkout that processes payment before any clinical review, is a significant red flag, the MHRA has warned repeatedly about illegally sold weight-loss medicines, including counterfeit pens that have caused serious harm. You can report suspect sellers through the MHRA Yellow Card scheme.
So the short answer: Klarna does not unlock Mounjaro. Clinical suitability does.
It helps to understand what you are actually paying for when you go through a legitimate private pharmacy. Since Eli Lilly raised UK list prices in September 2025, private Mounjaro has typically ranged roughly £149–£375 per month depending on the dose and provider, figures that have been widely reported and vary considerably across the market.
Some providers list a headline medicine price and add consultation fees, prescription charges and delivery on top. Others bundle everything. The difference matters when you are comparing. Our Mounjaro pricing page explains what the market looks like and what a single transparent price actually includes. At nume, one price covers the clinical consultation, prescription, medicine and free next-working-day delivery, no separate fees, no subscription you forget to cancel.
A note on timing: if your budget is tightest mid-month, it is worth knowing that at nume you order when you are ready. There is no rolling subscription. If payday falls on a Friday, you can order that Monday morning and, if clinically approved, your treatment dispatches the same day. That flexibility is built in by design.
For a prescription medicine, the cheapest listing answers the wrong question. The right questions are whether the pharmacy is GPhC-registered, whether a qualified prescriber is reviewing your case, and whether the supply chain is legitimate. You can verify any online pharmacy on the GPhC register, our registration number is 9012878.
Mounjaro's UK licence covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. BMI alone is never the whole picture, a prescriber reviews the complete clinical case. Our page on who can get Mounjaro covers the eligibility criteria in full, and there is more detail on the specific BMI thresholds at what BMI is needed for Mounjaro.
If you are close to the thresholds (say, a BMI of 27 or 28 with an existing health condition) it is worth reading about the BMI 27 pathway specifically, because eligibility is not a cliff-edge at 30. Lower thresholds can apply for some ethnic backgrounds under UK guidance too, which the eligibility pages explain.
NICE's appraisal of tirzepatide (TA1026) sets out the NHS criteria, which are stricter than the licensed indication. Private prescribing follows the licence, so your options through a regulated private pharmacy like nume may be broader than the NHS route. A prescriber at nume decides suitability, a consultation is where that conversation happens. If nausea is something that worries you going into treatment, our page on managing nausea alongside Mounjaro is worth a read before you start.
The step-by-step guide to getting Mounjaro walks through the full process from consultation to delivery if you want to see exactly what is involved. When you are ready, a free consultation with our clinical team is the place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.